Skip to content
Open access · CC-BY via OpenAlex

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease

Arno R. Bourgonje, Julius Z. H. von Martels, Ruben Y. Gabriëls, Tjasso Blokzijl, Manon Buist‐Homan, Janette Heegsma, Bernadien H. Jansen, Hendrik M. van Dullemen, Eleonora Anna Margaretha Festen, Rinze W. F. ter Steege, Marijn Caroline Visschedijk, Rinse Karel Weersma, Paul de Vos, Klaas Nico Faber, Gerard D. H. Dijkstra

Frontiers in Medicine · 2019 · ▲ 56 citations

Abstract

Introduction: Blood C-reactive protein (CRP) and fecal calprotectin levels are routinely measured as surrogate markers of disease activity in Inflammatory Bowel Disease (IBD), but often do not correlate well with the degree of mucosal inflammation in the intestine as established by endoscopy. Therefore, novel predictive biomarker(s) are urgently needed that better reflect mucosal disease activity in IBD. The aim of this study was to identify a combination of serum inflammatory biomarkers predictive for endoscopic disease activity. Methods: Serum concentrations of 10 inflammatory biomarkers were analyzed in 118 IBD patients (64 Crohn’s disease (CD), 54 ulcerative colitis (UC)) and 20 healthy controls. In a subset of 71 IBD patients, endoscopic disease activity was established. Nonparametric ROC estimation with bootstrap inference was used to establish the best combination of inflammatory biomarkers predicting endoscopic disease activity. Results: Six (6) inflammatory biomarkers (serum amyloid A (SAA), Eotaxin-1, IL-6, IL-8, IL-17A and TNF-α) showed better prediction of IBD disease activity than routine measures (CRP, fecal calprotectin and HBI/SCCAI scores). The best combination of predictive inflammatory biomarkers consisted of serum SAA, IL-6, IL-8 and Eotaxin-1, showing an optimism-adjusted area under the ROC curve of 0.84 (95% CI: 0.73 – 0.94, P < 0.0001), which predicted significantly better (P = 0.002) than serum CRP levels with an AuROC of 0.57 (95% CI: 0.43 – 0.72, P = 0.32). Conclusion: The combination of SAA, IL-6, IL-8 and Eotaxin-1 reliably predicts endoscopic disease activity in IBD and might be valuable for monitoring disease activity and management of the disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fmed.2019.00251
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Bourgonje, A.R., Martels, J.Z.H.V., Gabriëls, R.Y., Blokzijl, T., Buist‐Homan, M., Heegsma, J., Jansen, B.H., Dullemen, H.M.V., Festen, E.A.M., Steege, R.W.F.T., Visschedijk, M.C., Weersma, R.K., Vos, P.D., Faber, K.N., &amp; Dijkstra, G.D.H. (2019). A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease. <em>Frontiers in Medicine</em>. https://doi.org/10.3389/fmed.2019.00251
Vancouver
Bourgonje AR, Martels JZHV, Gabriëls RY, Blokzijl T, Buist‐Homan M, Heegsma J, et al. A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease. Frontiers in Medicine. 2019. doi:10.3389/fmed.2019.00251.
BibTeX
@article{arno2019ACombi, title = {A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease}, author = {Arno R. Bourgonje and Julius Z. H. von Martels and Ruben Y. Gabriëls and Tjasso Blokzijl and Manon Buist‐Homan and Janette Heegsma and Bernadien H. Jansen and Hendrik M. van Dullemen and Eleonora Anna Margaretha Festen and Rinze W. F. ter Steege and Marijn Caroline Visschedijk and Rinse Karel Weersma and Paul de Vos and Klaas Nico Faber and Gerard D. H. Dijkstra}, journal = {Frontiers in Medicine}, year = {2019}, doi = {10.3389/fmed.2019.00251}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings